Description
Maninil (Glibenclamide) Tablets 3.5 mg
Ingredients
Active Ingredient: Each tablet contains Glibenclamide 3.5 mg.
Dosage
Dosage: The typical starting dose is 2.5 to 5 mg per day, preferably taken with breakfast or the first main meal. Adjustments in dosage should be based on blood glucose levels.
Indications
Indicated for: Maninil tablets are prescribed for individuals with type 2 diabetes mellitus when diet and exercise alone are insufficient to manage blood glucose levels effectively.
Contraindications
Avoid Maninil tablets if you:
- Have type 1 diabetes
- Are experiencing diabetic ketoacidosis
- Are allergic to sulfonylureas
Directions
Usage Instructions: Take Maninil tablets orally with a meal. Adhere to the dosage guidance provided by your healthcare provider.
Scientific Evidence
Research indicates that Glibenclamide, the active component in Maninil tablets, reduces blood glucose levels by stimulating insulin release from the pancreas. This mechanism aids in managing hyperglycemia in type 2 diabetes patients.
Studies in the American Journal of Medicine have shown the effectiveness of Glibenclamide in lowering HbA1c levels and enhancing glycemic control compared to a placebo, underscoring its importance in diabetes treatment.
Additional Information
Regular monitoring of blood glucose levels is crucial while using Maninil tablets to ensure optimal diabetes control. Maintaining a healthy diet and exercise routine is vital for maximizing the benefits of this medication.
